A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.
AZoLifeSciences on MSN
AI Model 'MUSK' Advances Cancer Diagnosis with Multimodal Data Integration
Precision oncology aims to tailor cancer treatments to individual patients by analyzing diverse clinical and pathological ...
CAMBRIDGE, Mass., Dec. 17, 2025 /PRNewswire/ -- TileDB today announced the launch of TileDB Carrara, the omnimodal data intelligence platform, as a Snowflake Connected App for Healthcare & Life ...
This activity was supported by contracts between the National Academy of Sciences and Acadia Pharmaceuticals; Alzheimer’s Association; American Brain Coalition; American Neurological Association; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results